Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Celldex Therapeutics Appoints CMO | Contract Pharma

What are you searching for?

Sign in
Promotions & Moves

Celldex Therapeutics Appoints CMO

Young brings 30 years of experience leading clinical and cross-functional R&D teams

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Diane C. Young, M.D., has been appointed senior vice president, chief medical officer, Celldex Therapeutics, Inc., effective July 8, 2019. Dr. Young, a medical oncologist, has 30 years of experience leading clinical and cross-functional research and development teams responsible for the global development of numerous therapies from Phase I through product registrations. 

Dr. Young most recently served as the chief medical officer of GTx, Inc., a public biopharmaceutical company focused on developing small molecules that target nuclear hormone receptors. Previously, she spent 13 years at Novartis Oncology in senior leadership roles in global clinical development and medical affairs. As the head of Oncology Clinical Development, she directed the clinical programs for EXJADE, GLIVEC, FEMARA, AFINITOR, RYDAPT, JAKAVI and FARIDAK among others. Prior to Novartis, she held senior leadership positions in clinical development at the R.W. Johnson Pharmaceutical Research Institute of Johnson & Johnson, Hoffman-La Roche and Sandoz.

“Dr. Young’s notable career and strong track record of successful drug development make her an important addition to Celldex,” said Anthony Marucci, co-founder, president and chief executive officer of Celldex Therapeutics. “Her proven leadership will strengthen our clinical development efforts and support the continued progress of our product pipeline.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics